You have 9 free searches left this month | for more free features.

dasatinib

Showing 1 - 25 of 196

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

Recruiting
  • Waldenstrom Macroglobulinemia
  • DASATINIB
  • Dasatinib
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Dasatinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)

Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Prostate Cancer Trial (Dasatinib)

Withdrawn
  • Prostate Cancer
  • Dasatinib
  • (no location specified)
Feb 23, 2022

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Dasatinib
  • Decitabine and Cedazuridine
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Dasatinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 25, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Dasatinib
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

Recruiting
  • Chronic Myeloid Leukemia in Chronic Phase
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Jul 26, 2022

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)

Completed
  • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  • dasatinib
  • Valencia, Spain
    Hospital La Fe
Mar 16, 2022

Multiple Indications Cancer Trial in France, Poland (Dasatinib)

Active, not recruiting
  • Multiple Indications Cancer
  • Dasatinib
  • Besancon, France
  • +5 more
Dec 2, 2021

Breast Tumors, Triple Negative Breast Tumors Trial in Chicago, Madison (drug, procedure, other)

Terminated
  • Breast Neoplasms
  • Triple Negative Breast Neoplasms
  • Dasatinib
  • +2 more
  • Chicago, Illinois
  • +1 more
Jun 2, 2022

Aging Trial in Boston (Dasatinib, Quercetin)

Recruiting
  • Aging
  • Boston, Massachusetts
    Hebrew Senior Life
Jun 13, 2022

Breast Cancer, Bone Metastases Trial in Chicago, Durham, Houston (Dasatinib, Zoledronic Acid)

Completed
  • Breast Cancer
  • Bone Metastases
  • Dasatinib
  • Zoledronic Acid
  • Chicago, Illinois
  • +2 more
Feb 2, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Oct 12, 2021

EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

Active, not recruiting
  • EGFR Gene Mutation
  • Nonsmall Cell Lung Cancer
  • Washington, District of Columbia
  • +1 more
Jan 9, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Dasatinib
  • Amman, Jordan
  • +4 more
Jan 17, 2022

Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in

Completed
  • Refractory Chronic Lymphocytic Leukemia
  • +4 more
  • Dasatinib
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 15, 2021

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Mild Cognitive Impairment, Alzheimer Trial in Rochester (Dasatinib, Quercetin)

Enrolling by invitation
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 2, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Dasatinib
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 4, 2022

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • Dasatinib
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021

Pancreatic Cancer Metastatic Trial in Gainesville (Dasatinib, mFOLFOX6)

Completed
  • Pancreatic Cancer Metastatic
  • Gainesville, Florida
    UF Health Cancer Center
Dec 3, 2020

Leukemia Trial in Worldwide (Dasatinib)

Completed
  • Leukemia
  • Dasatinib
  • Vienna, Austria
  • +12 more
Feb 24, 2021